Figures 3N and S3g show that GC patients with increased JAK1 expression had significantly shorter OS and Progression‐Free‐Survival (PFS) than those with low JAK1 expression group using the online bioinformatics website Kaplan–Meier plotter. This evidence concerns the gene JAK1 and gastric cancer.